Browse > Article

Intensive management of acute right heart failure  

Kim, Gi Beom (Department of Pediatrics, Seoul National University College of Medicine)
Noh, Chung Il (Department of Pediatrics, Seoul National University College of Medicine)
Publication Information
Clinical and Experimental Pediatrics / v.50, no.11, 2007 , pp. 1041-1048 More about this Journal
Abstract
Not a few patients in children and adolescents are suffering from right ventricular (RV) dysfunction resulting from various conditions such as chronic lung disease, left ventricular dysfunction, pulmonary hypertension, or congenital heart defect. The RV is different from the left ventricle in terms of ventricular morphology, myocardial contractile pattern and special vulnerability to the pressure overload. Right ventricular failure (RVF) can be evaluated in terms of decreased RV contractility, RV volume overload, and/or RV pressure overload. The management for RVF starts from clear understanding of the pathophysiology of RVF. In addition to correction of the underlying disease, management of RVF per se is very important. Meticulous control of volume status, inotropic agents, vasopressors, and pulmonary selective vasodilators are the main tools in the management of RVF. The relative importance of each tool depends on the individual clinical status. Medical assist device and surgery can be considered selectively in case of refractory RVF to optimal medical treatment.
Keywords
Right ventricular failure; Blood volume; Cardiac inotropics; Vasopressor agents; Vasodilator agents;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Health Central-General Encyclopaedia-right-sided heart failure http://www.healthcentral.com/ency/408/000154.html Accessed September 2007
2 Mebazaa A, Karpati P, Renaud E, Algotsson L. Acute right ventricular failure-from pathophysiology to new treatments. Intensive Care Med 2004;30:185-96   DOI   ScienceOn
3 Goldhaber SZ, Elliott CG. Acute pulmonary embolism: Part I. Epidemiology, pathophysiology, and diagnosis. Circulation 2003;108:2726-9   DOI   ScienceOn
4 Kucher N, Goldhaber SZ. Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation 2003;108:2191-4   DOI   ScienceOn
5 Dabestani A, Mahan G, Gardin JM, Takenaka T, Burn C, Allfie A, et al. Evaluation of pulmonary artery pressure and resistance by pulsed Doppler echocardiography. Am J Cardiol 1987;59:662-8   DOI   ScienceOn
6 Gold J, Cullinane S, Chen J, Seo S, Oz MC, Oliver JA, et al. Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure. Am J Cardiol 2000;85:506-8   DOI   ScienceOn
7 Bhorade S, Christenson J, O Connor M, Lavoie A, Pohlman A, Hall TB. Response to inhaled nitric oxide in patients with acute right heart syndrome. Am J Respir Crit Care Med 1999;159:571-9   DOI   ScienceOn
8 Ng J, Finney S, Shulman R, Bellingan GJ, Singer M, Glynne PA. Treatment of pulmonary hypertension in the general adult intensive care unit: a role for oral sildenafil? Br J Anaesth 2005;94:774-7   DOI   ScienceOn
9 Morgan JA, John R, Lee BJ, Oz MC, Naka Y, et al. Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality. Ann Thorac Surg 2004;77:859-63   DOI   ScienceOn
10 Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007;93:1137-46   DOI
11 Rosenzweig EB, Barst RJ. Right-sided heart failure. In: Shaddy RE, Wernovsky G, editors. Pediatric heart failure. Taylor & Francis Group 2005:533-66
12 Gatecel C, Mebazaa A, Kong R, Guinard N, Kermarrec M, Mateo J, et al. Inhaled nitric oxide improves hepatic tissue oxygenation in right ventricular failure: value of hepatic venous oxygen saturation monitoring. Anesthesiology 1995; 82:588-90   DOI   ScienceOn
13 Pfisterer M. Right ventricular involvement in myocardial infarction and cardiogenic shock. Lancet 2003;362:392-4   DOI   ScienceOn
14 Hoeper MM, Olschewski H, Ghofrani HA, Wilkens H, Winkler J, Borst MM, et al. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group. J Am Coll Cardiol 2000;36:176-82
15 Nagaya N, Nishikimi T, Okano Y, Uematsu M, Satoh T, Kyotani S et al. Plasma brain natriuretic peptide levels in- crease in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998; 31:202-8   DOI
16 Kruger S, Graf J, Merx MW, Koch KC, Kunz D, Hanrath P, et al. Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism. Am Heart J 2004;147:60-5   DOI   ScienceOn
17 Ghofrani HA, Wiedemann R, Rose F, Olschewski H, Schermuly RT, Weissmann N, et al. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med 2002;136:515-22   DOI
18 Galie N, Hinderliter AL, Torbicki A, Fourme T, Simonneau G, Pulido T, et al. Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and Doppler measures in patients with pulmonary arterial hypertension. J Am Coll Cardiol 2003;41:1380-6   DOI   ScienceOn
19 Boxt LM. Radiology of the right ventricle. Radiol Clin North Am 1999;37:379-400   DOI
20 Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure(the LIDO study): a randomized double-blind trial. Lancet 2002;360:196-202   DOI   ScienceOn
21 King L, Wilkins MR. Natriuretic peptide receptors and the heart. Heart 2002;87:314-5   DOI
22 Vieillard-Baron A, Prin S, Chergui K, Cherqui K, Dubourq O, Jardin F. Hemodynamic instability in sepsis: bedside assessment by Doppler echocardiography. Am J Respir Crit Care Med 2003;168:1270-6   DOI   ScienceOn
23 Bendjelid K, Romand JA. Fluid responsiveness in mechanically ventilated patients: A review of indices used in intensive care. Intensive Care Med 2003;29:352-60   DOI
24 Stobierska-Dzierzek B, Awad H, Michler RE. The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol 2001;38:923-31   DOI   ScienceOn
25 Packer M. Vasodilator therapy for primary pulmonary hypertension. Limitations and hazards. Ann Intern Med 1985; 103:258-70   DOI   ScienceOn
26 Louie EK, Lin SS, Reynertson SI, Brundaqe BH, Levitsky S, Rich S. Pressure and volume loading of the right ventricle have opposite effects on left ventricular ejection fraction. Circulation 1995;92:819-24   DOI   ScienceOn
27 McNeil K, Dunning J, Morrell NW. The pulmonary physician in critical care: 13. The pulmonary circulation and right ventricular failure in the lTU. Thorax 2003;58:157-62   DOI
28 Vieillard-Baron A, Prin S, Chergui K, Dubourq O, Jardin F. Echo-Doppler demonstration of acute cor pulmonale at the bedside in the medical intensive care unit. Am J Respir Crit Care Med 2002;166:1310-9   DOI   ScienceOn
29 Jardin F, Vieillard-Baron A. Right ventricular function and positive pressure ventilation in clinical practice: from hemodynamic subsets to respirator settings. Intensive Care Med 2003;29:1426-34   DOI
30 Mahmud M, Champion HC. Right ventricular failure complicating heart failure: pathophysiology, significance, and management strategies. Curr Cardiol Rep 2007;9:200-8   DOI   ScienceOn
31 Piazza G, Goldhaber SZ. The acutely decompensated right ventricle: pathways for diagnosis and management. Chest 2005;128:1836-52   DOI   ScienceOn